Clinical Trial: Flortaucipir PET Imaging in Subjects With FTD

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional

Official Title: 18F-AV-1451 PET Imaging in Subjects With Frontotemporal Dementia

Brief Summary: This study is designed to assess the usefulness of 18F-AV-1451 in Positron Emission Tomography imaging for subjects diagnosed with Frontotemporal Dementia.

Detailed Summary:
Sponsor: Avid Radiopharmaceuticals

Current Primary Outcome: 18F-AV-1451 tracer uptake measured by regional SUVr [ Time Frame: 75 minutes post dose administration ]

To estimate SUVr (Standard Uptake Value Ratio) in FTD subjects


Original Primary Outcome: Same as current

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Avid Radiopharmaceuticals

Dates:
Date Received: January 31, 2017
Date Started: April 2017
Date Completion: December 2017
Last Updated: April 13, 2017
Last Verified: April 2017